全文获取类型
收费全文 | 77461篇 |
免费 | 7003篇 |
国内免费 | 4476篇 |
专业分类
耳鼻咽喉 | 910篇 |
儿科学 | 958篇 |
妇产科学 | 787篇 |
基础医学 | 9697篇 |
口腔科学 | 1373篇 |
临床医学 | 8466篇 |
内科学 | 11058篇 |
皮肤病学 | 1395篇 |
神经病学 | 3859篇 |
特种医学 | 3868篇 |
外国民族医学 | 21篇 |
外科学 | 7871篇 |
综合类 | 11997篇 |
现状与发展 | 28篇 |
一般理论 | 7篇 |
预防医学 | 5146篇 |
眼科学 | 2329篇 |
药学 | 8528篇 |
65篇 | |
中国医学 | 3915篇 |
肿瘤学 | 6662篇 |
出版年
2024年 | 116篇 |
2023年 | 821篇 |
2022年 | 1335篇 |
2021年 | 3302篇 |
2020年 | 2445篇 |
2019年 | 2245篇 |
2018年 | 2442篇 |
2017年 | 2316篇 |
2016年 | 2457篇 |
2015年 | 3686篇 |
2014年 | 4570篇 |
2013年 | 4525篇 |
2012年 | 6629篇 |
2011年 | 7041篇 |
2010年 | 4638篇 |
2009年 | 4003篇 |
2008年 | 4989篇 |
2007年 | 4702篇 |
2006年 | 4444篇 |
2005年 | 3918篇 |
2004年 | 2963篇 |
2003年 | 2964篇 |
2002年 | 2469篇 |
2001年 | 1674篇 |
2000年 | 1397篇 |
1999年 | 1248篇 |
1998年 | 790篇 |
1997年 | 700篇 |
1996年 | 599篇 |
1995年 | 542篇 |
1994年 | 518篇 |
1993年 | 344篇 |
1992年 | 374篇 |
1991年 | 343篇 |
1990年 | 288篇 |
1989年 | 262篇 |
1988年 | 173篇 |
1987年 | 182篇 |
1986年 | 139篇 |
1985年 | 96篇 |
1984年 | 55篇 |
1983年 | 38篇 |
1982年 | 38篇 |
1981年 | 26篇 |
1980年 | 27篇 |
1979年 | 16篇 |
1978年 | 6篇 |
1975年 | 7篇 |
1973年 | 10篇 |
1972年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
35.
Fei Xu Ming‐Liang Ye Yu‐Peng Zhang Wen‐Jie Li Meng‐Ting Li Hai‐Zhou Wang Xiao Qiu Yan Xu Jin‐Wen Yin Qian Hu Wan‐Hui Wei Ying Chang Lan Liu Qiu Zhao 《Cancer science》2020,111(5):1528-1541
Resistance to chemotherapy is a major challenge for the treatment of patients with colorectal cancer (CRC). Previous studies have found that microRNAs (miRNAs) play key roles in drug resistance; however, the role of miRNA‐373‐3p (miR‐375‐3p) in CRC remains unclear. The current study aimed to explore the potential function of miR‐375‐3p in 5‐fluorouracil (5‐FU) resistance. MicroRNA‐375‐3p was found to be widely downregulated in human CRC cell lines and tissues and to promote the sensitivity of CRC cells to 5‐FU by inducing colon cancer cell apoptosis and cycle arrest and by inhibiting cell growth, migration, and invasion in vitro. Thymidylate synthase (TYMS) was found to be a direct target of miR‐375‐3p, and TYMS knockdown exerted similar effects as miR‐375‐3p overexpression on the CRC cellular response to 5‐FU. Lipid‐coated calcium carbonate nanoparticles (NPs) were designed to cotransport 5‐FU and miR‐375‐3p into cells efficiently and rapidly and to release the drugs in a weakly acidic tumor microenvironment. The therapeutic effect of combined miR‐375 + 5‐FU/NPs was significantly higher than that of the individual treatments in mouse s.c. xenografts derived from HCT116 cells. Our results suggest that restoring miR‐375‐3p levels could be a future novel therapeutic strategy to enhance chemosensitivity to 5‐FU. 相似文献
36.
Zhai Shuting Lin Shuang Lin Zhongjie Xu Junjie Ji Tong Chen Ke Wu Ke Liu Hui Ying Hanning Fei Weiqiang Wang Jin Fu Guoxiang Wang Yifan Hu Xiaotong Cai Xiujun 《Gastric cancer》2020,23(3):483-496
Gastric Cancer - Epigenetic aberrations of tumor suppressor genes (TSGs), particularly DNA methylation, are frequently involved in the pathogenesis of gastric cancer (GC). Through a methylome... 相似文献
37.
38.
目的 初步探讨应用艾尔巴韦/格拉瑞韦治疗慢性丙型肝炎(CHC)患者的疗效。方法 2017年3月~2018年3月仙桃市第一人民医院感染病科收治的CHC患者82例,被随机分为对照组41例和观察组41例,分别给予聚乙二醇干扰素-α联合利巴韦林治疗和艾尔巴韦/格拉瑞韦治疗,两组均连续治疗24周。采用RT- PCR法检测血清 HCV RNA,采用全基因序列测定法行病毒基因分型。比较两组早期病毒学应答(EVR)、治疗结束时病毒学应答(ETVR)和持续病毒学应答(SVR)。结果 在治疗结束时,观察组血清丙氨酸氨基转移酶(ALT)水平为(47.9±19.7)U/L,显著低于对照组【(63.5±21.2)U/L,P<0.05】,天冬氨酸氨基转移酶(AST)水平为(55.5±22.3)U/L,显著低于对照组【(81.3±25.8)U/L,P<0.05】;观察组EVR、ETVR和SVR分别为48.8%、63.4%和70.7%,与对照组的41.5%、53.7%和65.8%比,无统计学差异(P>0.05);18例观察组非HCV Ⅰ型感染者EVR、ETVR和SVR分别为88.9%、94.4%和88.9%,显著高于同组23例HCV Ⅰ型感染者(分别为52.2%、60.9%和52.2%, P<0.05),而与对照组15例非HCV Ⅰ型感染者比,无统计学差异(分别为86.7%、93.3%和73.3%, P>0.05);观察组SVR12为87.8%(36/41),显著高于对照组的73.2%(30/41,P<0.05)。结论 应用直接抗病毒(DAA)药物艾尔巴韦/格拉瑞韦治疗CHC患者近期疗效达到,但远期疗效似优于标准治疗方案, 值得临床进一步验证。 相似文献
39.
Fluid is usually restricted during thoracic surgery, and vasoactive agents are often administered to maintain blood pressure. One-lung ventilation (OLV) decreases arterial oxygenation; thus oxygen delivery to the brain can be decreased. In this study, we compared phenylephrine and dopamine with respect to maintaining cerebral oxygenation during OLV in major thoracic surgery.Sixty-three patients undergoing lobectomies were randomly assigned to the dopamine (D) or phenylephrine (P) group. The patients’ mean arterial pressure was maintained within 20% of baseline by a continuous infusion of dopamine or phenylephrine. Maintenance fluid was kept at 5 mL/kg/h. The depth of anesthesia was maintained with desflurane 1MAC and remifentanil infusion under bispectral index guidance. Regional cerebral oxygen saturation (rScO2) and hemodynamic variables were recorded using near-infrared spectroscopy and esophageal cardiac Doppler.The rScO2 was higher in the D group than the P group during OLV (OLV 60 min: 71 ± 6% vs 63 ± 12%; P = 0.03). The number of patients whose rScO2 dropped more than 20% from baseline was 0 and 6 in the D and P groups, respectively (P = 0.02). The D group showed higher cardiac output, but lower mean arterial pressure than the P group (4.7 ± 1.0 vs 3.9 ± 1.2 L/min; 76.7 ± 8.1 vs 84.5 ± 7.5 mm Hg; P = 0.02, P = 0.02). Among the variables, age, hemoglobin concentration, and cardiac output were associated with rScO2 by correlation analysis.Dopamine was superior to phenylephrine in maintaining cerebral oxygenation during OLV in thoracic surgery. 相似文献
40.